Have a personal or library account? Click to login
Incidence, Predictors and Outcomes of Contrast Induced Nephropathy in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Cover

Incidence, Predictors and Outcomes of Contrast Induced Nephropathy in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Global Heart
Volume 16 (2021): Issue 1
By: Mohamed Khalfallah,  Amany Allaithy and  Dina A. Maria  
Open Access
|Aug 2021

References

  1. 1Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F, Bartorelli AL. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004 Nov 2; 44(9): 1780–5. DOI: 10.1016/j.jacc.2004.07.043
    Back to article
  2. 2Khalfallah M, Abdalaal M, Adel M. Contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction: Is it affected by treatment strategy? Global Heart. 2019 Sep; 14(3): 295–302. DOI: 10.1016/j.gheart.2019.07.001
    Back to article
  3. 3Morcos SK, Thomsen HS, Webb JAW. Contrast media induced nephrotoxicity: A consensus report. Contrast media safety committee, European Society of Urogenital Radiology (ESUR). Eur J Radiol. 1999; 9: 1602–13. DOI: 10.1007/s003300050894
    Back to article
  4. 4McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol. 2006; 98: 5K–13K. DOI: 10.1016/j.amjcard.2006.01.019
    Back to article
  5. 5Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006; S11–15. DOI: 10.1038/sj.ki.5000368
    Back to article
  6. 6Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011; 58: e44–122.
    Back to article
  7. 7Senoo T, Motohiro M, Kamihata H, et al. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Car- diol. 2010; 105: 624–8. DOI: 10.1016/j.amjcard.2009.10.044
    Back to article
  8. 8Brar SS, Aharonian V, Mansukhani P, et al. Hemodynamic guided fluid administration for the prevention of contrast-induced acute kidney injury: The POSEIDON randomised controlled trial. Lancet. 2014; 383: 1814–23. DOI: 10.1016/S0140-6736(14)60689-9
    Back to article
  9. 9Khalfallah M, Abdelmageed R, Allaithy A. Very Early Versus Early Percutaneous Coronary Intervention in Patients with Decreased e-GFR after Successful Fibrinolytic Therapy. Glob Heart. 2020 Apr 16; 15(1): 34. DOI: 10.5334/gh.794
    Back to article
  10. 10Menown IB, Mackenzie G, Adgey AA. Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction. Eur Heart J. 2000 Feb; 21(4): 275–83. DOI: 10.1053/euhj.1999.1748
    Back to article
  11. 11National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis. 2002 Feb; 39(2 Suppl 1): S1–266.
    Back to article
  12. 12Briguori C, Visconti G, Rivera NV, Focaccio A, Golia B, Giannone R, Castaldo D, De Micco F, Ricciardelli B, Colombo A. Cystatin C and contrast-induced acute kidney injury. Circulation. 2010; 121: 2117–2122. DOI: 10.1161/CIRCULATIONAHA.109.919639
    Back to article
  13. 13Van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, Menon V, Ohman EM, Sweitzer NK, Thiele H, Washam JB, Cohen MG. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017; 136: e232–e268. DOI: 10.1161/CIR.0000000000000525
    Back to article
  14. 14Rao SV, McCoy LA, Spertus JA, et al. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry. JACC Cardiovasc Interv. 2013; 6: 897–904. DOI: 10.1016/j.jcin.2013.04.016
    Back to article
  15. 15Kirma C, Izgi A, Dundar C, Tanalp AC, Oduncu V, Aung SM. Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center. Circ J. 2008; 72: 716–721. DOI: 10.1253/circj.72.716
    Back to article
  16. 16Mehran R, Aymong ED, Nikolsky, E, et al. A simple risk score for prediction of contrast4-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 44(2004): 1393–1399. DOI: 10.1016/S0735-1097(04)01445-7
    Back to article
  17. 17Bouzas-Mosquera A, Vazquez-Rodriguez JM, Calvino-Santos R, et al. Contrast induced nephropathy and acute renal failure following emergent cardiac catheterization: Incidence, risk factors and prognosis. Rev Esp Cardiol. 2007; 60: 1026–34. DOI: 10.1157/13111234
    Back to article
  18. 18Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 39(2002): 930–936. DOI: 10.1053/ajkd.2002.32766
    Back to article
  19. 19Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation 2003; 107: 2920. DOI: 10.1161/01.CIR.0000072767.89944.6E
    Back to article
  20. 20Khalfallah M, Elsheikh A. Incidence, predictors, and outcomes of new-onset atrial fibrillation in patients with ST-elevation myocardial infarction. Ann Noninvasive Electrocardiol. 2020 Jul; 25(4): e12746. Epub 2020 Jan 23. DOI: 10.1111/anec.12746
    Back to article
  21. 21Pizzetti F, Turazza FM, Franzosi MG, Barlera S, Ledda A, Maggioni AP, Santoro L, Tognoni G, GISSI-3 Investigators. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart. 2001; 86: 527–32. DOI: 10.1136/heart.86.5.527
    Back to article
  22. 22Diogo LP, Saitovitch D, Biehl M, Bahlis LF, Guterres MC, O’Keeffe CF, Carvalhal GF, Caramori PR. Is there an association between non-steroidal anti-inflammatory drugs and contrast nephropathy? Arq Bras Cardiol. 2010 Dec; 95(6): 726–31. Epub 2010 Nov 12. DOI: 10.1590/S0066-782X2010005000145
    Back to article
  23. 23Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002; 105: 2259–64. DOI: 10.1161/01.CIR.0000016043.87291.33
    Back to article
  24. 24Newhouse JH, RoyChoudhury A. Quantitating contrast medium-induced nephropathy: Controlling the controls. Radiology. 2013; 267: 4–8. DOI: 10.1148/radiol.13122876
    Back to article
  25. 25Kooiman J, Seth M, Nallamothu BK, Heung M, Humes D, Gurm HS. Association between acute kidney injury and in-hospital mortality in patients undergoing percutaneous coronary interventions. Circ Cardiovasc Interv. 2015; 8: e002212. DOI: 10.1161/CIRCINTERVENTIONS.114.002212
    Back to article
  26. 26Marenzi G, Assanelli E, Campodonico J, Lauri G, Marana I, De Metrio M, Moltrasio M, Grazi M, Rubino M, Veglia F, Fabbiocchi F, Bartorelli AL. Contrast volume during primary percutaneous coronary intervention and subsequent contrast induced nephropathy and mortality. Ann Intern Med. 2009; 150: 170–177. DOI: 10.7326/0003-4819-150-3-200902030-00006
    Back to article
  27. 27Narula A, Mehran R, Weisz G, Dangas GD, Yu J, Genereux P, Nikolsky E, Brener SJ, Witzenbichler B, Guagliumi G, Clark AE, Fahy M, Xu K, Brodie BR, Stone GW. Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI sub study. Eur Heart J. 2014; 35: 1533–1540. DOI: 10.1093/eurheartj/ehu063
    Back to article
DOI: https://doi.org/10.5334/gh.1071 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: May 31, 2021
Accepted on: Jul 23, 2021
Published on: Aug 31, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Contrast induced nephropathy,
ST elevation myocardial infarction,
primary percutaneous coronary intervention

© 2021 Mohamed Khalfallah, Amany Allaithy, Dina A. Maria, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 16 (2021): Issue 1Next article